206 related articles for article (PubMed ID: 34586712)
1. Prevalence of oral mucosal lesions in human immunodeficiency virus-infected children attending the Pediatric Infectious Diseases Clinic in Cape Town.
Mulder R; Mohamed N; Mathiba O
Clin Exp Dent Res; 2022 Feb; 8(1):160-168. PubMed ID: 34586712
[TBL] [Abstract][Full Text] [Related]
2. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
[TBL] [Abstract][Full Text] [Related]
3. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of HIV associated oral lesions among adults in the era of HAART.
Mthethwa SR; Wanjau J; Chabikuli N
SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
[TBL] [Abstract][Full Text] [Related]
5. The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa.
Malele Kolisa Y; Yengopal V; Shumba K; Igumbor J
PLoS One; 2019; 14(10):e0222568. PubMed ID: 31618211
[TBL] [Abstract][Full Text] [Related]
6. A real-world, cross sectional study of oral lesions and their association with CD4 cell counts and HIV viral load in Yunnan, China.
Shu W; Li C; Du F; Bai J; Duan K
Medicine (Baltimore); 2020 Oct; 99(40):e22416. PubMed ID: 33019418
[TBL] [Abstract][Full Text] [Related]
7. Oral lesions among HIV-infected children on antiretroviral treatment in West Africa.
Meless D; Ba B; Faye M; Diby JS; N'zoré S; Datté S; Diecket L; N'Diaye C; Aka EA; Kouakou K; Ba A; Ekouévi DK; Dabis F; Shiboski C; Arrivé E
Trop Med Int Health; 2014 Mar; 19(3):246-255. PubMed ID: 24386972
[TBL] [Abstract][Full Text] [Related]
8. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
10. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico.
Ramírez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Anaya-Saavedra G; González-Ramírez I; Ponce-de-León S
Medicine (Baltimore); 2003 Jan; 82(1):39-50. PubMed ID: 12544709
[TBL] [Abstract][Full Text] [Related]
11. Orofacial manifestations in HIV positive children attending Mildmay Clinic in Uganda.
Nabbanja J; Gitta S; Peterson S; Rwenyonyi CM
Odontology; 2013 Jan; 101(1):116-20. PubMed ID: 22362553
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of oral lesions and percent CD4+ T-lymphocytes in HIV-infected children on antiretroviral therapy.
Okunseri C; Badner V; Wiznia A; Rosenberg M
AIDS Patient Care STDS; 2003 Jan; 17(1):5-11. PubMed ID: 12614515
[TBL] [Abstract][Full Text] [Related]
14. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population.
Margiotta V; Campisi G; Mancuso S; Accurso V; Abbadessa V
J Oral Pathol Med; 1999 Apr; 28(4):173-7. PubMed ID: 10235371
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
[TBL] [Abstract][Full Text] [Related]
16. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
17. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
18. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
19. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of oral and systemic manifestations in pediatric HIV cohorts with and without drug therapy.
Jose R; Chandra S; Puttabuddi JH; Vellappally S; Al Khuraif AA; Halawany HS; Abraham NB; Jacob V; Hashim M
Curr HIV Res; 2013 Sep; 11(6):498-505. PubMed ID: 24329176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
